These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 17347558
21. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Vedder AC, Cox-Brinkman J, Hollak CE, Linthorst GE, Groener JE, Helmond MT, Scheij S, Aerts JM. Mol Genet Metab; 2006 Nov; 89(3):239-44. PubMed ID: 16765076 [Abstract] [Full Text] [Related]
22. Inflammatory cytokine levels in induced sputum and bronchoalveolar lavage fluid in pulmonary sarcoidosis. Balamugesh T, Behera D, Bhatnagar A, Majumdar S. Indian J Chest Dis Allied Sci; 2006 Nov; 48(3):177-81. PubMed ID: 18610674 [Abstract] [Full Text] [Related]
23. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Grosso S, Margollicci MA, Bargagli E, Buccoliero QR, Perrone A, Galimberti D, Morgese G, Balestri P, Rottoli P. Scand J Clin Lab Invest; 2004 Nov; 64(1):57-62. PubMed ID: 15025429 [Abstract] [Full Text] [Related]
24. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis. Nureki S, Miyazaki E, Ando M, Ueno T, Fukami T, Kumamoto T, Sugisaki K, Tsuda T. Respir Med; 2008 Feb; 102(2):239-47. PubMed ID: 17949965 [Abstract] [Full Text] [Related]
25. Analysis of serum amyloid A in sarcoidosis patients. Bargagli E, Magi B, Olivieri C, Bianchi N, Landi C, Rottoli P. Respir Med; 2011 May; 105(5):775-80. PubMed ID: 21215607 [Abstract] [Full Text] [Related]
26. The role of serum and bronchoalveolar lavage fluid chitotriosidase activity on diagnosis, disease characteristics and prognosis of sarcoidosis. Köycü Buhari G, Çiledağ A, Kurt İ, Çağlar E, Kaya A, Özdemir Kumbasar Ö, Çelik G. Tuberk Toraks; 2023 Dec; 71(4):367-377. PubMed ID: 38152007 [Abstract] [Full Text] [Related]
27. Chitotriosidase as a marker of disease activity in sarcoidosis. Brunner J, Scholl-Bürgi S, Zimmerhackl LB. Rheumatol Int; 2007 Oct; 27(12):1171-2. PubMed ID: 17534622 [Abstract] [Full Text] [Related]
28. Chitotriosidase as a marker of disease activity in sarcoidosis. Brunner J, Scholl-Bürgi S, Prelog M, Zimmerhackl LB. Rheumatol Int; 2007 Oct; 27(12):1185-6. PubMed ID: 17252260 [Abstract] [Full Text] [Related]
29. Angiogenic cytokines in induced sputum of patients with sarcoidosis. Fireman E, Gilburd D, Marmor S. Respirology; 2009 Jan; 14(1):117-23. PubMed ID: 18721182 [Abstract] [Full Text] [Related]
30. [Calcium metabolism in tuberculosis]. Shirai M, Sato A, Suda T, Shichi I, Yasuda K, Iwata M, Okano A, Genma H, Chida K. Kekkaku; 1990 Jun; 65(6):415-20. PubMed ID: 2388451 [Abstract] [Full Text] [Related]
31. [Levels of mucin-antigen 3EG5 in the blood and bronchoalveolar swabs in patients with tuberculosis, sarcoidosis and fibrosing alveolitis]. Stepanian IE, Lebedin IuS, Filippov VP, Kuklina GM, Chuchalin AG, Shmelev EI. Probl Tuberk; 2001 Jun; (3):60-2. PubMed ID: 11508240 [Abstract] [Full Text] [Related]
32. [The activity of immunocompetent cells and macrophages in pulmonary sarcoidosis (in comparison to tuberculosis)]. Gergert VIa, Abramova ZP, Kosmiadi GA. Probl Tuberk; 1996 Jun; (1):35-8. PubMed ID: 8907484 [Abstract] [Full Text] [Related]
40. Serum neopterin concentrations in healthy healthcare workers compared with healthy controls and patients with pulmonary tuberculosis. Ozdemir D, Cesur S, Annakkaya AN, Tarhan G, Hoca NT, Sencan I, Aslan T, Ceyhan I, Balbay O, Guclu E. Med Sci Monit; 2006 Dec; 12(12):CR521-524. PubMed ID: 17136008 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]